YVONNE KRIELOW: Open Payments
NPI 1881692218 · WELSH, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 14 payments from 7 companies in 2025. Trend: 2023 $646 · 2024 $231 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: JARDIANCE, Auvelity, BREZTRI, FARXIGA, CAPLYTA, Qelbree, VRAYLAR.
Industry payments across LA — which companies pay providers there.
